Subscribe

Attendo AB (publ) (ATT.ST)

SEK113.00 +2.20 (+1.99%)
SE STO Healthcare Medical - Care Facilities
Address VendevAegen 85 182 91
Danderyd, SE
CEO Martin Folke Tivéus
Website attendo.com
IPO 2015-11-30
ISIN SE0007666110

Explore sections of this company profile

Description

Founded in 1985 and based in Danderyd, Sweden, Attendo AB (publ) is a prominent provider of publicly financed care services across the Nordic countries, including Sweden, Finland, Norway, and Denmark. The company's extensive service portfolio addresses diverse care needs. For the elderly, it offers both residential care within nursing homes and in-home support. Individuals with disabilities benefit from specialized accommodations, assisted living arrangements, day programs, respite care, and short-term housing solutions. Attendo also provides services in social psychiatry, operating emergency shelters and family support homes. Its offerings further include social worker-backed foster care, immediate crisis and urgent accommodation, specialized HVB-homes (homes for care or accommodation), addiction treatment, and various supportive housing options. Furthermore, the company delivers home care services, often through outsourcing agreements.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK113.00 +2.20 (+1.99%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
363.3K
Beta
1.03
Float Shares
101.22M
Free Float %
70.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.67% +1.15% -1.22% +7.35% +27.83% +31.99% +70.23% +208.96% +161.43% +31.50% +50.29%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
113.00
DCF (Unlevered) 494.84 +337.9%
DCF (Levered) 432.06 +282.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.44
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Care Facilities: +10.2%
    +0.1% Q1'26: -1.6% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +90.2% ★ Q1'26: +54.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +13.6% Q1'26: +12.6% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +9.6% Q1'26: +9.4% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +7.0% ★ Q1'26: +6.7% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -4.8% ★ Q1'26: -4.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    4.25× Q1'26: 4.18× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.00) × ERP
WACC = 49% × Ke + 51% × Kd (4.9%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 494.84 Current price: 113.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
2 EPS Ana. 		Dec 2027
1 Rev. Ana.
2 EPS Ana. 		Dec 2028
1 Rev. Ana.
2 EPS Ana. 		Dec 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
9.83B
est: 9.75B (+0.9%)
10.21B
est: 10.28B (-0.7%)
11.16B
est: 11.19B (-0.3%)
10.99B
est: 11.24B (-2.2%)
11.94B
est: 11.92B (+0.1%)
12.29B
est: 12.26B (+0.2%)
12.87B
est: 12.85B (+0.1%)
14.50B
est: 14.41B (+0.6%)
17.29B
est: 18.14B (-4.7%)
18.98B
est: 18.98B (0.0%)
18.99B
est: 18.91B (+0.4%)
18.92B
18.92B – 18.92B
+0.0% YoY
19.77B
19.77B – 19.77B
+4.5% YoY
20.68B
20.65B – 20.72B
+4.6% YoY
22.27B
22.27B – 22.27B
+7.7% YoY
EBITDA
1.05B
est: 1.47B (-28.2%)
1.13B
est: 1.55B (-26.9%)
1.07B
est: 1.69B (-36.8%)
2.03B
est: 1.69B (+19.9%)
1.93B
est: 1.80B (+7.4%)
1.11B
est: 1.85B (-40.0%)
1.99B
est: 1.94B (+2.9%)
2.18B
est: 2.17B (+0.2%)
3.05B
est: 4.78B (-36.2%)
3.44B
est: 5.01B (-31.2%)
3.87B
est: 4.99B (-22.4%)
4.99B
4.99B – 4.99B
+0.0% YoY
5.21B
5.21B – 5.21B
+4.5% YoY
5.45B
5.44B – 5.46B
+4.6% YoY
5.87B
5.87B – 5.87B
+7.7% YoY
EBIT
737.00M
est: 419.43M (+75.7%)
894.00M
est: 442.32M (+102.1%)
776.00M
est: 481.51M (+61.2%)
852.00M
est: 483.53M (+76.2%)
661.00M
est: 513.03M (+28.8%)
-271.00M
est: 527.68M (-151.4%)
581.10M
est: 552.99M (+5.1%)
618.00M
est: 620.05M (-0.3%)
1.28B
est: 2.87B (-55.4%)
1.43B
est: 3.01B (-52.5%)
1.82B
est: 2.99B (-39.3%)
3.00B
3.00B – 3.00B
+0.0% YoY
3.13B
3.13B – 3.13B
+4.5% YoY
3.27B
3.27B – 3.28B
+4.6% YoY
3.53B
3.53B – 3.53B
+7.7% YoY
Net Income
286.00M
est: 343.34M (-16.7%)
649.00M
est: 690.61M (-6.0%)
680.00M
est: 730.22M (-6.9%)
1.03B
est: 609.25M (+69.4%)
81.00M
est: 145.38M (-44.3%)
-904.00M
est: 90.66M (-1,097.1%)
56.00M
est: 204.98M (-72.7%)
-45.00M
est: 89.87M (-150.1%)
376.00M
est: 369.94M (+1.6%)
450.00M
est: 513.16M (-12.3%)
813.00M
est: 765.23M (+6.2%)
1.02B
990.36M – 1.05B
+33.5% YoY
1.14B
1.12B – 1.17B
+12.0% YoY
1.27B
1.25B – 1.28B
+10.6% YoY
1.26B
1.26B – 1.26B
-0.4% YoY
SGA
1.65B
est: 938.40M (+76.2%)
1.85B
est: 989.60M (+86.4%)
2.04B
est: 1.08B (+89.5%)
1.54B
est: 1.08B (+42.7%)
1.76B
est: 1.15B (+53.2%)
1.82B
est: 1.18B (+54.5%)
1.83B
est: 1.24B (+48.1%)
2.26B
est: 1.39B (+63.1%)
288.00M
est: 1.28B (-77.4%)
338.00M
est: 1.33B (-74.7%)
355.00M
est: 1.33B (-73.3%)
1.33B
1.33B – 1.33B
+0.0% YoY
1.39B
1.39B – 1.39B
+4.5% YoY
1.45B
1.45B – 1.46B
+4.6% YoY
1.57B
1.57B – 1.57B
+7.7% YoY
EPS
1.79
est: 2.18 (-17.8%)
4.06
est: 4.38 (-7.3%)
4.26
est: 4.63 (-8.0%)
6.43
est: 3.86 (+66.4%)
0.50
est: 0.92 (-45.8%)
-5.62
est: 0.58 (-1,077.4%)
0.35
est: 1.30 (-73.1%)
-0.28
est: 0.57 (-149.1%)
2.34
est: 2.47 (-5.1%)
2.86
est: 3.42 (-16.4%)
5.45
est: 5.10 (+6.9%)
6.81
6.60 – 7.02
+33.5% YoY
7.63
7.45 – 7.81
+12.0% YoY
8.44
8.32 – 8.55
+10.6% YoY
8.40
8.40 – 8.40
-0.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-08 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-07 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-06 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-05 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-04 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-30 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-29 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-28 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-27 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-24 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-23 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-22 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-21 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-20 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-17 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-16 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
2.36B
OE per share TTM
15.73
Owner's Yield
15.40%
Maintenance CapEx ratio
50.54%
Maint CapEx / Avg PPE
75.1%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 90 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 2C XBCU.L 1.62% 12.40M 0.29%
2 Xtrackers Bloomberg Commodity ex-Agriculture & Livestock Swap UCITS ETF 3C GBP Hedged XDBG.L 1.62% 12.39M 0.39%
3 NYLI International Small-Mid Cap Equity ETF NISM 0.61% 153.2K 0.70%
4 WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE 0.24% 223.0K 0.38%
5 WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L 0.24% 223.0K 0.38%
6 iShares OMX Stockholm Capped UCITS ETF OM3X.DE 0.17% 362.8K 0.10%
7 iShares Ageing Population UCITS ETF AGED.L 0.13% 1.13M 0.40%
8 Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L 0.10% 3.27M 0.30%
9 iShares MSCI Europe Small-Cap ETF IEUS 0.09% 155.9K 0.41%
10 WisdomTree Dynamic International SmallCap Equity ETF DDLS 0.09% 370.4K 0.48%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
55.1K
Shares Outstanding
144.41M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Martin Folke Tivéus Chief Executive Officer & President 11M male
Josefine Uppling Communications & Sustainability Director — female
Malin Fredgardh Huber Managing Director of Attendo Scandinavia — female
Carl Granström General Counsel — male
Mikael Malmgren Chief Financial Officer — male
Stefan Svanstrom Head of Community Communications — male
Virpi Holmqvist Managing Director of Attendo Finland — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities